Talphera (TLPH) Tax Provisions (2015 - 2023)
Talphera (TLPH) posted Tax Provisions of -$3.9 million for Q4 2023, down 193450.0% on a QoQ basis from $2000.0 in Q3 2023, and down 138.6% year-over-year from $10.0 million in Q4 2022.
Analysis
Talphera (TLPH) Tax Provisions (2015 - 2023) Analysis & Trends
Talphera has reported Tax Provisions for 9 years, with the latest figure at -$3.9 million in Q4 2023.
- On a quarterly basis, Tax Provisions fell 138.6% year-over-year to -$3.9 million in Q4 2023; TTM through Sep 2024 was -$3.9 million, a 138.52% decrease from a year earlier, with the FY2023 full-year figure at -$3.9 million, down 138.5% from the prior year.
- Tax Provisions was -$3.9 million for Q4 2023 at Talphera, down from $2000.0 in the prior quarter.
- The five-year high for Tax Provisions was $10.0 million in Q4 2022, with the low at -$11.2 million in Q4 2019.
- Average Tax Provisions over 5 years is -$1.7 million, with a median of $3000.0 recorded in 2019.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions surged 235.82% in 2022, then slumped 138.6% in 2023.
- Over 5 years, Tax Provisions stood at -$11.2 million in 2019, then gained by 24.08% to -$8.5 million in 2020, then rose by 13.13% to -$7.4 million in 2021, then soared by 235.82% to $10.0 million in 2022, then plunged by 138.6% to -$3.9 million in 2023.
- The last three Tax Provisions figures came in at -$3.9 million (Q4 2023), $2000.0 (Q3 2023), and $3000.0 (Q2 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.58 Bn | 192.59 Bn | 7.24 Bn | 393.00 Mn |
| 2 | Gilead Sciences | 180.17 Bn | 176.99 Bn | 6.22 Bn | 242.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.59 Bn | 122.74 Bn | 2.84 Bn | 292.00 Mn |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.61 Bn | 3.93 Bn | 230.90 Mn |
| 5 | Argenx Se | 60.24 Bn | 55.05 Bn | 1.37 Bn | -59.00 Mn |
| 6 | Moderna | 54.29 Bn | 49.15 Bn | 52.00 Mn | 15.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.96 Bn | 29.65 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Biogen | 31.94 Bn | 30.66 Bn | 1.96 Bn | 34.90 Mn |
| 9 | Roivant Sciences | 29.38 Bn | 29.38 Bn | 1.16 Mn | -3.96 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -3.87 Mn |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Dec 31, 2022 | 10.02 Mn |
| Sep 30, 2022 | 11,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Dec 31, 2021 | -7.38 Mn |
| Jun 30, 2021 | 5,000.00 |
| Dec 31, 2020 | -8.49 Mn |
| Jun 30, 2020 | 4,000.00 |
| Dec 31, 2019 | -11.18 Mn |
| Jun 30, 2019 | 3,000.00 |
| Dec 31, 2018 | -9.90 Mn |
| Jun 30, 2018 | 2,000.00 |
| Dec 31, 2017 | 34.10 Mn |
| Jun 30, 2017 | 2,000.00 |
| Dec 31, 2016 | -14.65 Mn |
| Sep 30, 2016 | -36,000.00 |
| Mar 31, 2016 | 2,000.00 |
| Dec 31, 2015 | -8.81 Mn |